NEW YORK (

TheStreet

) --

AstraZeneca

(NYSE:

AZN

) hit a new 52-week high Friday as it is currently trading at $55.93, above its previous 52-week high of $55.15 with 686,214 shares traded as of 9:50 a.m. ET. Average volume has been 1.3 million shares over the past 30 days.

AstraZeneca has a market cap of $66.79 billion and is part of the health care sector and drugs industry. Shares are up 16.3% year to date as of the close of trading on Thursday.

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for cardiovascular, gastrointestinal, neuroscience, infection, oncology, and respiratory and inflammation diseases worldwide. The company has a P/E ratio of 10.7, below the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates

AstraZeneca

TST Recommends

as a

buy

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full

AstraZeneca Ratings Report

.

See all

52-week high stocks

or get investment ideas from our

investment research center

.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more

.

null